20.01.2016 • News • Elaine Burridge • Board • Life Science

Merck Appoints Executive Board Members

Germany’s Merck KGaA has appointed two new executive board members. Udit...
Germany’s Merck KGaA has appointed two new executive board members. Udit Batra and Walter Galinat, heads of the Life Science and Performance Materials business sectors respectively, will join the board as of Apr. 30. They will retain their previous business responsibilities.

Germany’s Merck KGaA has appointed two new executive board members. Udit Batra and Walter Galinat, heads of the Life Science and Performance Materials business sectors respectively, will join the board as of Apr. 30. They will retain their previous business responsibilities.

Bernd Reckmann, the incumbent board member responsible for Life Science and Performance Materials, will retire on Apr. 29.Since the beginning of 2015, Merck KGaA has been organized into three sectors: Healthcare, Life Science and Performance Materials, each of which will now be directly represented on the executive board.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature

most read

Photo
28.07.2025 • News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.